Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : ALTA NATURAL HERBS & SUPPLEMENTS LTD. (AHS-ASE) -- Ignore unavailable to you. Want to Upgrade?

To: reg who wrote (34)	11/13/1998 10:00:00 PM
From: Robert G. Hanah	Respond to of 66

It's all gonna be in the translation...kinda like BRE-X ! We'll see on Monday!

To: reg who wrote (34)	11/15/1998 2:18:00 PM
From: JDW	Read Replies (2) \| Respond to of 66

Reg, Your question identifies you as woefully uninformed and possibly without the initiative or capacity to do the most basic research. A quick scan through company news releases clearly answers your questions. On July 21 it was announced that initial North American testing involving 100 patients had begun with the first results expected in 30-45 days. On Sept.18 the company announced that results to that time supported the conclusions of the 17 pre-clinical and clinical trials conducted in Europe and the initial participant limit of 100 would be increased due to overwhelming demand from Hepatitis-C sufferers from around the world. This is a legitimate company in the process of implementing a business plan to capitalize on a growing demand for alternatives to conventional medical treatment. There is also is huge, and still growing, demand from the "boomers" for products to preserve or enhance the lives of those lucky enough to have good health. There is no reason to believe that company releases are not factual and to mention Bre-X as a possible comparison as was done in a previous post is absolutely ridiculous. My additional research has led me to believe that the potential of Hepatico is at this point being grossly understated. Do not take my word for it though, you can either do your own research or wait until the stock is recommended again by another newsletter in the future, likely at a price may times higher than it is today.